Gray matter atrophy distinguishes between Parkinson disease motor subtypes

Neurology

Volumn 80, Issue 16, 2013, Pages 1476-1484

  Rosenberg Katz, Keren ^a   Herman, Talia ^a,b   Jacob, Yael ^a,b   Giladi, Nir ^a,b   Hendler, Talma ^a,b   Hausdorff, Jeffrey M ^a,b,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GRAY MATTER ATROPHY; HUMAN; LIMBIC CORTEX; LIMBIC SYSTEM; MALE; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSTURAL INSTABILITY GAIT DIFFICULTY; POSTURAL INSTABILITY TREMOR DOMINANT; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PUTAMEN; SYMPTOM; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; CLASSIFICATION; IMAGE PROCESSING; MIDDLE AGED; MOTOR DYSFUNCTION; NERVE CELL NETWORK; NERVE TRACT; NEUROLOGIC GAIT DISORDER; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RISK FACTOR; STATISTICAL ANALYSIS;

ANTIPARKINSON AGENT; LEVODOPA;

AGED; ANTIPARKINSON AGENTS; ATROPHY; BRAIN; COGNITION; DATA INTERPRETATION, STATISTICAL; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NERVE NET; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; RISK FACTORS;

MLCS; MLOWN;

EID: 84878756678     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31828cfaa4     Document Type: Article

References (40)

1. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-1534.
2. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005;76:343-348.
3. Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:585-589.
4. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
5. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-1798.
6. Fjell AM, Walhovd KB, Fennema-Notestine C, et al. Oneyear brain atrophy evident in healthy aging. J Neurosci 2009;29:15223-15231.
7. Raz N, Gunning-Dixon F, Head D, Rodrigue KM. Williamson A, Acker JD. Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: eplicability of regional differences in volume. Neurobiol Aging 2004;25:377-396.
8. Raz N, Lindenberger U, Rodrigue KM, et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 2005;15:1676-1689.
9. Zhang H, Sachdev PS, Wen W, et al. Gray matter atrophy patterns of mild cognitive impairment subtypes. J Neurol Sci 2012;315:26-32.
10. Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV. Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiol Aging 2011;32:1733-1741.
11. Dumurgier J, Crivello F, Mazoyer B, et al. MRI atrophy of the caudate nucleus and slower walking speed in the elderly. Neuroimage 2012;60:871-878.
12. Pan PL, Song W, Shang HF. Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson's disease. Eur J Neurol 2011;19:199-206.
13. Linder J, Birgander R, Olsson I, et al. Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson's disease in a population-based cohort. J Neurol 2009;256:1671-1680.
14. Wu T, Wang L, Chen Y, Zhao C, Li K, Chan P. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease. Neurosci Lett 2009;460:6-10.
15. Ni Z, Pinto AD, Lang AE, Chen R. Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol 2010;68:816-824.
16. Mito Y, Yoshida K, Yabe I, et al. Brain SPECT analysis by 3D-SSP and phenotype of Parkinson's disease. J Neurol Sci 2006;241:67-72.
17. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300.
19. Sankoh AJ, Huque MF, Dubey SD. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 1997;16:2529-2542.
20. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233-1239.
21. Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995;34:537.
22. Peltier SJ, Noll DC. T (2) (*) dependence of low frequency functional connectivity. Neuroimage 2002;16:985-992.
23. Cunnington R, Windischberger C, Deecke L, Moser E. The preparation and execution of self-initiated and externally-triggered movement: a study of event-related fMRI. Neuroimage 2002;15:373-385.
24. Lau HC, Rogers RD, Haggard P, Passingham RE. Attention to intention. Science 2004;303:1208-1210.
25. Shima K, Mushiake H, Saito N, Tanji J. Role for cells in the presupplementary motor area in updating motor plans. Proc Natl Acad Sci USA 1996;93:8694-8698.
26. Meppelink AM, De Jong BM, Teune LK, Van Laar T. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations. Mov Disord 2010;26:142-147.
27. Alon G, Yungher DA, Shulman LM, Rogers MW. Safety and immediate effect of noninvasive transcranial pulsed current stimulation on gait and balance in Parkinson disease. Neurorehabil Neural Repair 2010;26:1089-1095.
28. Thach WT, Goodkin HP, Keating JG. The cerebellum and the adaptive coordination of movement. Annu Rev Neurosci 1992;15:403-442.
29. Morton SM, Bastian AJ. Mechanisms of cerebellar gait ataxia. Cerebellum 2007;6:79-86.
30. Benninger DH, Thees S, Kollias SS, Bassetti CL, Waldvogel D. Morphological differences in Parkinson's disease with and without rest tremor. J Neurol 2009;256:256-263.
31. Atkinson HH, Rosano C, Simonsick EM, et al. Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2007;62:844-850.
32. Mirelman A, Herman T, Brozgol M, et al. Executive function and falls in older adults: new findings from a five-year prospective study link fall risk to cognition. PLoS One 2012;7:e40297.
33. Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord 2008;23:329-342.
34. Kostic VS, Agosta F, Petrovic I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010;75:857-863.
35. Nishio Y, Hirayama K, Takeda A, et al. Corticolimbic gray matter loss in Parkinson's disease without dementia. Eur J Neurol 2010;17:1090-1097.
36. Pereira JB, Junqué C, Marti MJ, Ramirez-Ruiz B, Bargalló N, Tolosa E. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009;24:1193-1199.
37. Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005;128:1259-1266.
38. Tir M, Delmaire C, Le Thuc V, et al. Motor-related circuit dysfunction in MSA-P: usefulness of combined whole-brain imaging analysis. Mov Disord 2009;24:863-870.
39. Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 2008;23:42-46.
40. Jubault T, Brambati SM, Degroot C, et al. Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI. PLoS One 2009;4:e8247.